Swedish Biotech and Medtech Delegation to Singapore - IONLACE AB (2025)
| Reference number | |
| Coordinator | IONLACE AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | September 2025 - September 2025 |
| Status | Completed |
| Venture | Global cooperation 2025 |
Important results from the project
The trip to Singapore was successful. We achieved our goals in learning more about the Singaporean ecosystem, and Asia more broadly. We look forward to building on top of the new connections and relationships that we established during the trip and Asia Bio conference.
Expected long term effects
In the long term, we hope to build on this to create positive commercial relationships and partnerships with companies in Asia.
Approach and implementation
The schedule was managed by the project planners, we only participated. We had a number of scheduled visits to various actors in the ecosystem in addition to the Asia Bio conference. It was good to follow the schedule with arranged transportation to get across Singapore.